Wardwizard Healthcare Ltd (WARDHEALTH) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Wardwizard Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
Intimation under Regulation 30 for Allotment of Fully Convertible Warrants
Others (Uncategorized) · 05 Nov 2026, 12:23 am
Wardwizard Healthcare Approves Allotment of 1.087 Crore Convertible Warrants Wardwizard Healthcare approved the preferential allotment of 1,08,70,000 warrants convertible into equity shares (face value Rs. 10 each) at an issue price of Rs. 10 per warrant on 4th Nov'26. The issue size was reduced from 1,25,00,000 warrants following non-participation by one proposed investor and a subscription reduction by promoter Yatin Sanjay Gupte. The company received an upfront payment of Rs. 2.72 crore (25%), with total issue value at Rs. 10.87 crore. The warrants are exercisable within 18 months, subject to statutory lock-in.
Intimation under Regulation 30 of SEBI (LODR) 2015 for appointment of Ms. Diksha Sharma (DIN : 11914278) as an Additional Director in the Capacity as an Independent Director of the Company ....
Change in Management · 31 Oct 2026, 1:49 am
Wardwizard Healthcare Appoints Diksha Sharma as Additional Independent Director Wardwizard Healthcare Limited’s Board approved the appointment of Ms. Diksha Sharma (DIN: 11914278) as an Additional Independent Woman Director (Non-Executive) for a 5-year term effective 30th Oct'26, subject to shareholder approval. Sharma is an advocate enrolled with the Bar Council of Rajasthan, empanelled with the Indian Institute of Corporate Affairs, and currently serves as an Independent Director at Decillion Finance, Nirmalkunj Merchandise, and Premkunj Distributor. The company confirmed she is not debarred by SEBI or any other authority and holds no relationships with existing directors.
Pursuant to Regulation 30 _Intimation of Appointment of new Internal Auditor and resignation of Previous Internal Auditor as attached herewith
Change in Management · 31 Oct 2026, 1:43 am
Wardwizard Healthcare Appoints Tania Dey as Internal Auditor Following Auditor Resignation Wardwizard Healthcare Limited announced that internal auditor M/s Upadhyay & Company, Chartered Accountants, resigned effective 30th Oct'26 due to time constraints and other professional commitments, citing no other material reasons. Following the Audit Committee's recommendation, the Board of Directors approved the appointment of Ms. Tania Dey, Advocate & Compliance Consultant, as the new Internal Auditor effective 30th Oct'26 for FY27. Ms. Dey brings five years of post-qualification experience in legal risk management, statutory compliance auditing, and regulatory frameworks.
Unaudited Financial Results for the Quarter ended 30th September 2026 as attached herewith for the reference
Financial Result · 31 Oct 2026, 1:37 am
Wardwizard Healthcare Q2 FY27 Results: Net Profit Reaches ₹21.95 Lakh Wardwizard Healthcare reported total income of ₹186.94 lakh for the quarter ended 30th Sep'26, rising sharply from ₹65.40 lakh QoQ and ₹0.21 lakh YoY. Revenue from operations stood at ₹123.11 lakh alongside other income of ₹63.83 lakh. Total expenses expanded to ₹167.38 lakh from ₹102.39 lakh QoQ and ₹26.16 lakh YoY. The company posted a net profit of ₹21.95 lakh compared to net losses of ₹32.06 lakh in Q1 FY27 and ₹26.02 lakh in Q2 FY26. Diluted EPS stood at ₹8.61.
OUTCOME OF THE BOARD MEETING HELD ON 30TH OCTOBER 2026 to Consider and approve the Unaudited Financial Results along with Limited Review Report for the quarter and six months ended 30thSeptember ....
Outcome · 31 Oct 2026, 1:30 am
Wardwizard Healthcare Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 123 (+88.2% QoQ) ■ EBITDA: -39.9 (-76.6% YoY | -20.1% QoQ) ■ EBITDA Margin (%): -32.4 (+1837 bps QoQ) ■ PAT: 22.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 8.61 (Loss to Profit YoY | Loss to Profit QoQ)
Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Intimation · 30 Oct 2026, 5:30 am
Wardwizard Healthcare Schedules Board Meeting for Q2 Earnings Wardwizard Healthcare Limited has scheduled a Board of Directors meeting on 30th Oct'26 to consider and approve the unaudited financial results for the quarter and half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for directors, designated persons, and their immediate relatives remains closed from the end of the quarter until 1st Nov'26, reopening on 2nd Nov'26.
E-Voting Results of 42nd Annual General Meeting along with Scrutinizer ''s Report
Annual General Meeting · 05 Oct 2026, 1:00 am
Proceeding of the 42nd Annual General Meeting of the Company
Annual General Meeting · 01 Oct 2026, 12:22 am
Attached herewith Corrigendum to Notice of 42nd Annual General Meeting of the Company
Annual General Meeting · 20 Sept 2026, 12:21 am
Wardwizard Healthcare Issues AGM Corrigendum on ₹8 Crore Preferential Investment Wardwizard Healthcare Limited issued a corrigendum to its 42nd AGM notice scheduled for 30th Sep'26, clarifying the objects of its preferential issue of fully convertible warrants following BSE queries. The company specified that ₹8.00 crore from the issue proceeds will be invested entirely in promoter group firm Wardwizard Medicare Private Limited via 2% Non-Cumulative Convertible Preference Shares to fund healthcare business expansion across its four hospitals and Ayurvedic centre. It confirmed that no proceeds will be used for debt repayment or diverted to other promoter entities.
Attached herewith intimation for dispatch of letter to shareholder for purpose of Annual Generall Meeting
Annual General Meeting · 05 Sept 2026, 10:58 pm
Wardwizard Healthcare Dispatches AGM Notice and FY26 Annual Report Web-Link Wardwizard Healthcare Limited has dispatched letters to shareholders whose email addresses are unregistered, providing web-links for its FY26 Annual Report and the notice for its 42nd Annual General Meeting scheduled on 30th Sep'26 at 15:00 IST via video conferencing. The cut-off date for eligibility was 28th Aug'26. Additionally, the company reminded physical security holders to update mandatory KYC details—including PAN, bank information, specimen signatures, and nominations—to ensure dividend and corporate benefit distributions remain eligible via electronic mode pursuant to SEBI mandates.
Notice of the 42nd Annual General Meeting of the Members of the Company scheduled to be held on Wednesday , 30th September 2026 at 3:00 P.M
Annual General Meeting · 05 Sept 2026, 9:58 pm
Submission of Notice of 42nd Annual General Meeting (AGM) and Annual Report for the Financial Year 2025-26.
Others (Uncategorized) · 05 Sept 2026, 9:53 pm
Appointment of Directors
Change in Management · 01 Sept 2026, 4:20 am
Wardwizard Healthcare Announces Key Board Appointments Wardwizard Healthcare announced two key board appointments on 31st Aug'26. Ms. Sathi Kundu was appointed Additional Independent Woman Director, effective 31st Aug'26, for a five-year term. Mr. Yuvraj Priyadarshi, previously appointed CEO on 14th Nov'25, will now also serve as Whole-Time Director effective 30th Sep'26 for a five-year term. Both appointments are subject to shareholder approval. These changes aim to strengthen the company's board structure and corporate governance.
Issue of Fully Convertible Warrants
Others (Uncategorized) · 01 Sept 2026, 4:17 am
Wardwizard Healthcare to Raise ₹12.5 Crore via Preferential Warrant Issue Wardwizard Healthcare's board approved issuing up to 1.25 crore fully convertible warrants on a preferential basis for cash at ₹10 each, aggregating up to ₹12.5 crore. The issue, dated 31-Aug-26, allots warrants to both promoter and non-promoter groups. Promoters Yatin Gupte and Sheetal Bhalerao will be allotted 52 lakh and 18 lakh warrants respectively. Proceeds will fund growth, expansion, working capital, and general corporate purposes. Each warrant is convertible into one equity share within 18 months from the allotment date.
Increased in Authorised Capital
Others (Uncategorized) · 01 Sept 2026, 4:06 am
Wardwizard Healthcare Proposes to Increase Authorised Share Capital Wardwizard Healthcare's board approved a proposal to increase its authorised share capital on 31 Aug'26. The plan is to raise the capital from ₹7.50 crores (7.5 million shares of ₹10) to ₹25 crores (2.5 million shares of ₹10). This significant increase from the existing capital structure signals potential future fundraising activities or corporate actions. The proposal is subject to necessary approvals and amendments to the company's Memorandum and Articles of Association. The meeting concluded at 8:50 p.m.
Outcome of the Board Meeting held on 31st August, 2026
Outcome · 01 Sept 2026, 4:03 am
Wardwizard Healthcare To Raise Capital via Warrants and Increase Authorized Capital On 31st Aug'26, Wardwizard Healthcare's board approved raising its authorized share capital from ₹7.5 Cr to ₹25 Cr. The company will also issue up to 1.25 Cr convertible warrants on a preferential basis at ₹10 each, aggregating to ₹12.5 Cr. These warrants, convertible into equity shares within 18 months, will be allotted to promoter and non-promoter groups. Proceeds will fund growth, expansion, and working capital. The board also approved key appointments, including a new Independent Director and a Whole-Time Director.
Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 ,inter alia, to consider and approve (i)discussion and consideration ....
Intimation · 24 Aug 2026, 11:40 pm
Wardwizard Healthcare to Consider Fundraising and Increasing Authorized Share Capital Wardwizard Healthcare has scheduled a Board Meeting for 31 Aug'26 to consider a proposal for raising further capital. The fundraising may occur via equity shares, equity-linked instruments, convertible securities, ADRs/GDRs, or debt instruments through public offers, private placements, QIPs, or preferential allotments. The board will also discuss increasing the company's authorized share capital. The trading window for designated persons is closed from 24 Aug'26 until 48 hours after the meeting's outcome is announced.
Attached herewith the Unaudited Financial Results for the First Quarter ended 30th June 2026
Financial Result · 14 Aug 2026, 1:00 am
Wardwizard Healthcare Q1FY27: Revenue Rises Amidst Widening Losses Wardwizard Healthcare reported a net loss of ₹36.99 lacs for Q1FY27 ended Jun'26, widening from a loss of ₹9.55 lacs YoY but improving from a profit of ₹31.65 lacs QoQ. Revenue from operations grew 236.7% YoY to ₹65.40 lacs, also up 14.5% QoQ. However, total expenses surged to ₹102.39 lacs, a significant increase from ₹72.81 lacs YoY and ₹57.13 lacs QoQ, driven by higher employee and material costs. The company reported a negative EPS of ₹18.00 for the quarter.
Pursuant to Regulation 30, 33 and schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company at its meeting held today, ....
Outcome · 14 Aug 2026, 12:32 am
Wardwizard Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lacs) ■ Revenue: 65.4 (+236.8% YoY | +14.5% QoQ) ■ EBITDA: -33.2 (+16.6% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -50.8 (+15416 bps YoY | Profit to Loss QoQ) ■ PAT: -32.1 (-54.1% YoY | Profit to Loss QoQ) ■ EPS (INR): -18.0 (-135.6% YoY | Profit to Loss QoQ)
Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Pursuance to Regulation ....
Intimation · 13 Aug 2026, 5:30 am
Wardwizard Healthcare Board Meeting to Approve Q1FY27 Results on 13th Aug'26 Wardwizard Healthcare Ltd (BSE: 512063) has scheduled a Board of Directors meeting on 13th Aug'26 to consider and approve the un-audited standalone financial results for the first quarter ended 30th Jun'26. In relation to this, the trading window for designated persons, which closed on 1st Jul'26, will remain shut until 15th Aug'26. The trading window is set to reopen on 17th Aug'26, following the declaration of the financial results.
Pursuant to Regulation 30 of SEBI (LODR)2015, this is to inform you that the Company has changed its official website w.e.f 16th July 2026 and the details of the same as been attached ....
Others (Uncategorized) · 16 Jul 2026, 7:51 pm
Wardwizard Healthcare Announces Official Website Domain Change Wardwizard Healthcare Ltd (formerly Ayoki Mercantile Ltd) has changed its official website address to https://wardwizardhealthcare.com/, effective 16 Jul'26. The previous domain, www.ayokimerchantile.com, will now automatically redirect to the new site. This change aligns with the company's updated branding. All regulatory disclosures, corporate information, and financial results for BSE script code 512063 will be hosted on the new website. The update was filed under Regulation 30 of SEBI Listing Regulations.
Pursuant to Regulation 30 of SEBI(LODR)2015 ,this is to inform you that on the recommendation of Audit Committee, the Board has approved the appointment of Statutory Auditor of the Company .
Change in Auditor · 16 Jul 2026, 7:40 pm
Wardwizard Healthcare Appoints MGSA & Company as New Statutory Auditor Wardwizard Healthcare's board approved the appointment of MGSA & Company (FRN: 022481C) as its new statutory auditor, effective from 16th Jul'26. The appointment fills a casual vacancy created by the resignation of M/s. Mahesh Udhwani & Associates. MGSA & Company is also proposed for a five-year term, subject to shareholder approval at the upcoming AGM. This decision was based on the Audit Committee's recommendation.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has appointed Statutory Auditor of the Company on the Board meeting Held ....
Others (Uncategorized) · 16 Jul 2026, 7:30 pm
Wardwizard Appoints New Statutory Auditor and Updates Corporate Website Wardwizard Healthcare board approved appointing M/s MGSA & Company (FRN: 022481C) as statutory auditor on 16th Jul'26. The firm fills a casual vacancy from the resignation of M/s. Mahesh Udhwani & Associates and is appointed for a five-year term from the FY26-27 AGM to the FY30-31 AGM. The board also approved changing the official website from ayokimerchantile.com to wardwizardhealthcare.com, effective 16th Jul'26, to align with the company's new branding. The previous website will automatically redirect to the new domain.
Attached herewith the intimation of Resignation of Statutory Auditor w.e.f 14th May 2026
Change in Auditor · 15 Jun 2026, 11:21 pm
Wardwizard Healthcare Auditor Resigns Citing Non-Receipt of Information M/s Mahesh Udhwani & Associates has resigned as Statutory Auditor of Wardwizard Healthcare Limited effective 14th May'26. The resignation letter cites "non-receipt of the required information, records, and supporting documents in a timely manner despite repeated requests" as the reason for being unable to discharge their professional responsibilities. The auditor's term was scheduled to expire on 30th Sep'28. The company filed the intimation with the exchange on 15th Jun'26, acknowledging a delay in the disclosure which it attributed to an inadvertent oversight.
Attached herewith the intimation of Resignation of Independent Director w.e.f. 30th June 2026
Change in Management · 09 Jun 2026, 11:51 pm
Wardwizard Healthcare Director Resigns, Effective End of June 2026 Mr. Miteshkumar Ghanshyambhai Rana has resigned as Non-Executive Independent Director of Wardwizard Healthcare (WARDHEALTH), effective from the close of business on 30th Jun'26. The resignation is attributed to personal commitments and increased professional engagements. Concurrently, he will cease to be a member of the Audit Committee and Chairperson of the Nomination and Remuneration Committee. The company confirmed no other material reasons for his departure. The resignation was tendered on 09th Jun'26.